Literature DB >> 2970950

High teicoplanin uptake by human neutrophils.

E G Maderazo1, S P Breaux, C L Woronick, R Quintiliani, C H Nightingale.   

Abstract

The cellular/extracellular (C/E) concentration ratio of teicoplanin in polymorphonuclear leukocytes (PMNs) increased rapidly with time (C/E 60 +/- 13 at 20 min). The C/E ratio was time- and concentration-dependent. At 20 min and an initial concentration of 75 +/- 16 micrograms/ml the cellular drug concentration was 4,700 +/- 1,300 micrograms/ml. The mechanism of drug uptake was by an active process and transported (cellular) drug retained its antimicrobial activity. Washing removed 42% of cellular drug. Teicoplanin inhibited PMN chemotaxis at very high concentrations and PMN microbicidal activity at lower concentrations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970950     DOI: 10.1159/000238576

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  8 in total

Review 1.  Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.

Authors:  Rina Mehrotra; Raffaele De Gaudio; Mark Palazzo
Journal:  Intensive Care Med       Date:  2004-11-05       Impact factor: 17.440

Review 2.  Immunomodulating effects of antibiotics: literature review.

Authors:  B Van Vlem; R Vanholder; P De Paepe; D Vogelaers; S Ringoir
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

3.  Mixed-lipid storage disorder induced in macrophages and fibroblasts by oritavancin (LY333328), a new glycopeptide antibiotic with exceptional cellular accumulation.

Authors:  Françoise Van Bambeke; Jennifer Saffran; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

4.  Antimicrobial activity against intraosteoblastic Staphylococcus aureus.

Authors:  Florent Valour; Sophie Trouillet-Assant; Natacha Riffard; Jason Tasse; Sacha Flammier; Jean-Philippe Rasigade; Christian Chidiac; François Vandenesch; Tristan Ferry; Frédéric Laurent
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

5.  Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery.

Authors:  M G Bergeron; R Saginur; D Desaulniers; S Trottier; W Goldstein; P Foucault; C Lessard
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

6.  Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]teicoplanin in experimental Staphylococcus aureus infection of joint prostheses.

Authors:  A Saleh Mghir; A C Crémieux; R Bleton; F Ismael; M Manteau; S Dautrey; L Massias; L Garry; N Sales; B Mazière; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.

Authors:  Françoise Van Bambeke; Stéphane Carryn; Cristina Seral; Hugues Chanteux; Donatienne Tyteca; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

Review 8.  In vitro antibiotic activity against intraosteoblastic Staphylococcus aureus: a narrative review of the literature.

Authors:  Florian C Marro; Lélia Abad; Ariel J Blocker; Frédéric Laurent; Jérôme Josse; Florent Valour
Journal:  J Antimicrob Chemother       Date:  2021-11-12       Impact factor: 5.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.